12.1 Antigen-Antibody Principles

CMLA Work Area III (Examination / Analytical Considerations) is 83 items, or 41.5% of the 200-question exam. Immunology, serology, and immunohematology is competency 7. AMT III.7.A.1–2 requires terminology plus the principles of antigen–antibody reaction. Named terms in this cluster include antigen, antibody, agglutination, hemolysis, blood, serum, and plasma. The same outline list also names kits and fibrinogen; kits are Section 12.3, and fibrinogen sits with plasma proteins and blood-bank tubes in Section 12.2.

Quick Answer: An antigen is what an antibody binds. Binding can look like agglutination (clumping) or, in the blood bank, hemolysis (red-cell lysis as a positive reaction). Qualitative tests say present or absent; quantitative tests report a number or titer. A false negative can come from prozone (too much antibody for a visible lattice), an expired kit, or insufficient specimen. Immunology is not chemistry.

Immunology and chemistry are not the same question

Immunology studies the immune system. Serology is the laboratory application that detects antigen–antibody reactions, classically in serum. Immunohematology (blood bank) uses the same reactions on red-cell antigens and plasma antibodies that decide transfusion compatibility. Clinical chemistry measures metabolites, enzymes, electrolytes, and many hormones by chemical, enzymatic, or spectrophotometric methods.

Some chemistry assays are immunoassays (for example, thyroid-stimulating hormone). On CMLA that overlap is not permission to rename departments. A glucose meter asks how much glucose is in the specimen. A Strep A cassette asks whether Group A streptococcal antigen is detectable. Treating a lateral-flow infectious-disease kit as a “chemistry level,” or treating an electrolyte panel as serology, is the designed trap.

Antigen and antibody

An antigen is a substance the immune system can recognize. In the laboratory it is often a protein, glycoprotein, or polysaccharide on a microbe, on a cell surface, or as a soluble molecule such as human chorionic gonadotropin (hCG). Patient red cells carry antigens (A, B, D). Pathogens carry antigens (Group A streptococcal carbohydrate, influenza proteins, HIV p24).

An antibody (immunoglobulin) is a protein made by B lymphocytes / plasma cells that binds a specific antigen. The five classes are IgG, IgM, IgA, IgD, and IgE. For CMLA, two classes do most of the work:

• IgM appears early in many infections. It is pentameric and a strong agglutinin. ABO isoagglutinins (anti-A, anti-B) and many heterophile antibodies in infectious mononucleosis are classically IgM.
• IgG appears later and persists. It crosses the placenta. Unexpected blood-group antibodies that cause delayed hemolytic transfusion reactions and hemolytic disease of the fetus and newborn are often IgG.

The antigen–antibody reaction is specific binding: the antibody’s antigen-binding site fits an epitope on the antigen. Visible laboratory endpoints include:

1. Agglutination — particles (red cells, latex beads, bacteria) clump because antibodies cross-link surface antigens. Rheumatoid-factor latex agglutination, a heterophile mono test, and forward ABO typing (patient red cells plus reagent anti-A or anti-B) are agglutination methods.
2. Hemolysis — rupture of red blood cells. In immunohematology, complement-fixing antibodies can lyse red cells; hemolysis is then a positive serologic reaction. In specimen quality (Chapter 7), hemolysis is pink-red plasma or serum from a traumatic draw and is a rejection problem. The stem tells you which meaning is in play. Do not treat blood-bank hemolysis as “the tube was drawn badly, so report negative.”
3. Precipitation / flocculation — soluble antigen and antibody form a lattice that becomes visible. Classic rapid plasma reagin (RPR) charcoal flocculation belongs in this family.
4. Labeled immunoassay — antigen or antibody tagged with a dye or enzyme. Waived lateral-flow cassettes are this idea inside a plastic housing: a test line means the labeled complex was captured; a control line means the device flowed.

Blood, serum, and plasma in serology

Blood is the starting specimen. Plasma is the liquid from anticoagulated blood and still contains fibrinogen. Serum is the liquid after blood has clotted; fibrinogen has been consumed (Section 6.2). Many classic serology methods were validated on serum from a clot tube. Many waived kits now specify whole blood, plasma, serum, or urine. Visual color does not identify the matrix: fresh plasma and serum can both be straw-yellow. Using the wrong liquid is an invalid result and off-label use (Chapter 5). Do not pour plasma onto a serum-only cassette, and do not assume “any yellow liquid” matches the insert.

Qualitative versus quantitative

A qualitative test answers present or absent (reactive/nonreactive, positive/negative) at a labeled cutoff. Waived Strep A, many HIV screens, influenza antigen, RSV antigen, urine hCG, and many RPR screens are qualitative.

A quantitative test reports a number: a concentration, a titer, or an index. Serum quantitative hCG and RPR titers (1:2, 1:4, 1:8…) are quantitative. Quantitative methods are often not waived. A CMLA may perform a qualitative urine pregnancy test per the instructions for use (IFU); independently running a quantitative serum hCG immunoassay is typically moderate- or high-complexity work (Section 12.3).

Do not “upgrade” a qualitative cassette into a quantity by staring at line darkness. Intensity is not a validated concentration unless the IFU says it is—almost never on waived antigen kits.

Why a true reaction can look negative

Lattice formation needs antigen and antibody in a workable ratio.

Prozone is antibody excess: so much antibody that antigen sites are coated and few antibody bridges form. Agglutination or flocculation can look negative. Teach this at a simple level: too much antibody can cause a false-negative clumping or RPR-style test. A classic blood-bank and syphilis teaching example is a very high-titer specimen that looks nonreactive until it is diluted—when a nonwaived procedure says to dilute. A CMLA does not invent a dilution on a waived cassette to “fix prozone.” That modification defaults the method to high complexity (Section 5.1).

Postzone is antigen excess: too much antigen, not enough antibody to cross-link—also a false-negative lattice. The hook effect on some hCG immunoassays is the same idea (very high antigen). Same rule: do not freelance dilutions on waived kits.

Other false-negative causes AMT expects you to prevent before the cassette ever reaches a read window:

False positives exist too: reading after the stop time (evaporation or ghost lines), contaminated swabs, and nonspecific clumping. Expired reagent and short samples remain the favorite false-negative stems.

What the CMLA actually does with these principles

You do not titer antibodies at the chair. You collect the specimen the insert names, confirm the kit is in date and stored correctly, apply the labeled volume, and read inside the window. Treat agglutination, a test line, or (in blood bank) hemolysis as the IFU defines them—not as a chemistry number. A negative agglutination test can still be wrong if antibody was in excess (prozone idea), the kit was dead, or the sample was too small.

Scenario

A rheumatoid-factor latex test shows no clumping. The pouch expired last month, and only half the labeled serum drop was applied. Do not report “RF negative.” Expiration and insufficient specimen can each cause a false-negative antigen–antibody reaction. Use in-date reagent at the labeled volume, or send a method the laboratory is certified to perform.

Exam traps

• Calling serum and plasma interchangeable yellow liquids in serology.
• Treating hemolysis only as a bad draw; in immunohematology it can be a positive reaction.
• Reading line darkness as a quantitative result.
• Diluting a waived cassette to “fix prozone.”
• Calling a Strep A cassette a chemistry test because it is a “level.”

Keep the reaction valid by matching antigen, antibody, matrix, volume, dating, and time—then report only what the method is designed to say.